|
中國中藥控股有限公司, 00570.HK - 綜合損益表 |
2023-12 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
2008-12 |
2007-12 |
2006-12 |
2005-12 |
營業額 |
18,121,861 |
14,304,242 |
19,052,802 |
14,806,168 |
14,320,949 |
11,258,941 |
8,337,795 |
6,532,867 |
3,709,406 |
2,650,454 |
1,394,613 |
1,268,143 |
1,015,935 |
939,178 |
670,175 |
443,533 |
355,880 |
831,378 |
824,038 |
經營溢利 |
1,427,277 |
1,064,283 |
2,753,058 |
2,490,631 |
2,460,716 |
2,156,025 |
1,786,453 |
1,376,783 |
689,160 |
551,696 |
272,757 |
289,815 |
102,144 |
119,061 |
95,786 |
54,783 |
34,164 |
-480,435 |
-825,358 |
非經營/ 特殊項目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-3,831 |
-5,321 |
-1,378 |
-1,258 |
0 |
0 |
聯營公司 |
-3,699 |
-3,479 |
-10,749 |
-15,874 |
-5,051 |
-7,028 |
1,852 |
444 |
-1,637 |
-62,577 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
除稅前經營溢利 |
1,224,533 |
840,109 |
2,520,280 |
2,230,091 |
2,154,618 |
1,856,697 |
1,567,237 |
1,303,804 |
689,160 |
489,119 |
237,575 |
265,984 |
94,455 |
115,230 |
90,465 |
53,405 |
32,906 |
-480,435 |
-825,358 |
稅項 |
-171,537 |
119,357 |
396,856 |
369,447 |
381,321 |
289,669 |
255,804 |
217,264 |
119,106 |
70,386 |
38,218 |
53,330 |
20,747 |
29,151 |
22,239 |
4,938 |
7,871 |
-48,741 |
-18,195 |
少數股東權益 |
110,870 |
-43,514 |
190,566 |
197,389 |
185,183 |
128,010 |
140,999 |
119,613 |
18,453 |
-1,544 |
894 |
5,520 |
1,636 |
25,154 |
24,172 |
28,137 |
16,639 |
-94,293 |
-44,584 |
股東應占溢利 |
1,285,200 |
764,266 |
1,932,858 |
1,663,255 |
1,588,114 |
1,439,018 |
1,170,434 |
966,927 |
625,596 |
413,090 |
198,463 |
207,134 |
72,072 |
60,925 |
44,054 |
20,330 |
8,396 |
-337,401 |
-762,579 |
貨幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
單位 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
主要項目 |
折舊 |
1,133,271 |
1,099,397 |
849,597 |
684,079 |
590,826 |
509,662 |
403,716 |
326,638 |
155,343 |
107,288 |
68,281 |
46,693 |
57,106 |
29,478 |
28,606 |
19,563 |
18,674 |
89,992 |
93,956 |
利息 |
199,045 |
220,695 |
223,248 |
244,666 |
329,783 |
306,952 |
221,068 |
73,423 |
70,180 |
62,577 |
35,182 |
30,284 |
13,530 |
3,831 |
5,321 |
1,378 |
1,258 |
15,741 |
18,555 |
利息撥作發展資本 |
0 |
0 |
1,219 |
0 |
28,736 |
14,652 |
0 |
0 |
0 |
0 |
0 |
6,453 |
5,841 |
0 |
0 |
0 |
0 |
0 |
0 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
-14.01 |
14.21 |
15.75 |
16.57 |
17.7 |
15.6 |
16.32 |
16.66 |
17.28 |
14.39 |
16.09 |
20.05 |
21.96 |
25.3 |
24.58 |
9.25 |
23.92 |
|
|
營業額增長(%) |
26.69 |
-24.92 |
28.68 |
3.39 |
27.2 |
35.03 |
27.63 |
76.12 |
39.95 |
90.05 |
9.97 |
24.83 |
8.17 |
40.14 |
51.1 |
24.63 |
-57.19 |
0.89 |
11.25 |
股東應占溢利增長(%) |
68.16 |
-60.46 |
16.21 |
4.73 |
10.36 |
22.95 |
21.05 |
54.56 |
51.44 |
108.14 |
-4.19 |
187.4 |
18.3 |
38.3 |
116.69 |
142.14 |
|
|
|
核數師意見 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|